Importantly, our discovery that EZH2 coordinates EMT–MET is in consonance with previous reports studying lung cancer cells where it has been shown that the loss of function of EZH2 hinders repression of mesenchymal genes during MET [8], and reduces tumour colonisation capacity in mouse models [6–8]. This evidence concerns the gene EZH2 and lung carcinoma.